EBRAHIM VERSI, M.D.
Medical Practice at City West Pkwy, Edina, MN
License number
Minnesota 81853
Category
Medical Practice
Type
Gynecologic Oncology
Address
Address
2
6585 City West Pkwy WEST, Edina, MN 55344
11 Sheephill Dr, Gladstone, NJ 07934
11 Sheephill Dr, Gladstone, NJ 07934
Phone
(908) 698-2390
Professional information
Dr. Ebrahim Versi, Eden Prairie MN - MD (Doctor of Medicine)
Specialties:
Obstetrics & Gynecology
Address:
6585 City West Pkwy, Eden Prairie 55344
(908) 698-2390 (Phone)
(908) 698-2390 (Phone)
Languages:
English
Compositions For Treatment Of Postmenopausal Female Sexual Dysfunction
US Patent:
2003013, Jul 10, 2003
Filed:
Nov 12, 2002
Appl. No.:
10/292742
Inventors:
Christopher Bilkey - Epping, AU
J. Slatter - Chester NJ, US
Ebrahim Versi - Gladstone NJ, US
J. Slatter - Chester NJ, US
Ebrahim Versi - Gladstone NJ, US
International Classification:
A61K031/56
US Classification:
514/170000
Abstract:
A set of pharmaceutical dosage forms is provided, each comprising at least two therapeutic agents selected from (a) an estrogen, (b) an androgen, and (c) an antimuscarinic, in total and relative dosage amounts that are therapeutically effective in treatment of female sexual dysfunction (FSD) or postmenopausal sexual avoidance (PMSA), said dosage forms being adapted for intravaginal administration. A method of treatment of FSD or PMSA comprises administering intravaginally, in a treatment regimen extending over a period of at least 7 days, dosage forms at least a portion of which comprise two or more therapeutic agents selected from (a) an estrogen, (b) an androgen, and (c) an antimuscarinic, in total and relative dosage amounts that are therapeutically effective in treatment of FSD or PMSA, wherein no more than one dosage form is administered on any day. Also provided is a kit useful in implementing such a treatment regimen.
Method Of Using Cyclooxygenase Inhibitors And Antimuscarinic Agents
US Patent:
2003019, Oct 9, 2003
Filed:
Feb 18, 2003
Appl. No.:
10/368091
Inventors:
Ebrahim Versi - Gladstone NJ, US
International Classification:
A61K031/415, A61K031/365
US Classification:
514/406000, 514/473000
Abstract:
The present invention provides a method for the use of a cyclooxygenase-2 inhibitor, alone or in combination with an anti-muscarinic agent, for the treatment or prophylaxis of a urinary incontinence condition in a subject in need of such treatment or prevention, comprising administering to the subject an effective amount of the cyclooxygenase-2 inhibitor and, optionally, the anti-muscarinic agent.
Method And Device For Delivering Drug To The Trigone Of The Bladder
US Patent:
2009017, Jul 2, 2009
Filed:
Sep 3, 2008
Appl. No.:
12/231532
Inventors:
Ebrahim Versi - Gladstone NJ, US
International Classification:
A61M 5/32
US Classification:
604511, 604173
Abstract:
Methods of treating functional disorders of the bladder in mammalian females are disclosed. A therapeutic compound is delivered directly into the trigone of the bladder. The therapeutic may be delivered to the trigone through the vaginal wall. A device for delivering the therapeutic compound is also disclosed. The device may be an array of microneedles connected to a reservoir.
Self-Catheterization Device To Administes Compounds To The Bladder
US Patent:
2009017, Jul 2, 2009
Filed:
Mar 10, 2006
Appl. No.:
12/225084
Inventors:
Ebrahim Versi - Gladstone NJ, US
International Classification:
A61M 25/14, A61K 39/08, A61P 13/10
US Classification:
604517, 604246, 4242361
Abstract:
Devices and methods for self catheterization and for instilling fluid into the bladder are disclosed. A catheter device is provided for inserting into the urethra of an individual by the subject him or herself for the purpose of instilling a therapeutic compound into the bladder. The catheter assembly includes a catheter that has an opening near the tip, a valve mechanism, and a reservoir at the opposite end from the tip. The catheter may be provided with separate channels for draining the bladder and instilling a therapeutic compound into the bladder. Methods for self catheterization and self-administration of a therapeutic compound into the bladder by a patient are disclosed.
Combination Therapy
US Patent:
2003011, Jun 26, 2003
Filed:
Nov 7, 2002
Appl. No.:
10/289903
Inventors:
Ebrahim Versi - Gladstone NJ, US
International Classification:
A61K031/137, A61K009/70, A61K009/48, A61K009/20
US Classification:
424/449000, 514/649000, 424/465000, 424/451000
Abstract:
The invention relates to a method of treating unstable or overactive urinary bladder, wherein the method comprises administering to a patient in need of such treatment an antimuscarinic agent in a pharmaceutically effective amount thereof and estrogen agonist in a pharmaceutically effective amount thereof. The antimuscarinic agent is preferably tolterodine or a tolterodine-related compound. The invention also relates to a pharmaceutical formulation containing an antimuscarinic agent, estrogen agonist and pharmaceutically excipients and the use of the combination for the manufacture of a therapeutical formulation for treating unstable or overactive urinary bladder.